Ajay Sheshadri, MD, discusses the advantages of attending CHEST 2023 in person and how these benefits can inspire positive change even after the conference ends.
Seeing colleagues in person at the CHEST Annual Meeting 2023 is a valued opportunity after the COVID-19 pandemic and provides advantages for all areas of medicine even after the conference ends, explains Ajay Sheshadri, MD, associate professor of pulmonary medicine at the University of Texas MD Anderson Cancer Center.
Transcript
Why is it beneficial for chest medicine professionals to meet in person at CHEST 2023?
I think we probably took for granted how great it is to see our colleagues in person before the pandemic. During the pandemic, most of our conferences were virtual, and the engagement with the virtual conference is a lot more difficult. You're not there in person seeing the speakers, you're not able to interact with the speakers, other than through a chat box or perhaps a very closely moderated Q&A, and it doesn't quite feel like you're in a research retreat environment.
So, being around people of like-minded interests really just stimulates your own desire to advance the field forward, and I think gives you a lot of energy to be able to motivate yourself when you come back from the conference. Usually, after the conference, there's a little bit of a buzz as you synthesize all the things that you saw and discussed at the conference. To me, that's been incredibly beneficial. Usually after the meetings, there's a flurry of activity and new collaborations and new ideas, and I think you only really get that when you’re there in person and really in the moment.
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Specialty Pharmacists at the Forefront: Elevating Care for Rare Diseases
May 1st 2024In the US, a disease is considered rare when it affects fewer than 200,000 persons, or 1 in every 1500 individuals, with an estimated total of 25 to 30 million Americans overall living with a rare disease at any given time.
Read More
Joanne Mizell: Lifestyle Modification Programs Take Holistic Aim at Metabolic Disease
May 1st 2024Joanne Mizell shares insurer strategies in addressing the escalating rates of metabolic diseases, highlighting the importance of holistic treatment methods like lifestyle modification programs, which integrate nutrition, physical activity, and community engagement.
Read More